✦ LIBER ✦

Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal

✍ Scribed by Vallet-Pichard, A.; Pol, S.

Book ID: 126594941
Publisher: SAGE Publications
Year: 2014
Tongue: English
Weight: 414 KB
Volume: 7
Category: Article
ISSN: 1756-283X
DOI: 10.1177/1756283X14524614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of hepatitis C virus in speci

Management of hepatitis C virus in special populations: Patient and treatment considerations

✍ Gish, Robert G.; Afdhal, Nezam H.; Dieterich, Douglas T.; Reddy, K. Rajender 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Treatment of hepatitis B in special pati

Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation

✍ Hans Ludger Tillmann; Heiner Wedemeyer; Michael Peter Manns 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Tenofovir for the Treatment of Hepatitis

Tenofovir for the Treatment of Hepatitis B Virus

✍ Dr. Alice M. Jenh; Dr. Chloe L. Thio; Dr. Paul A. Pham 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Guidelines for the treatment of chronic

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

✍ Hiromitsu Kumada; Takeshi Okanoue; Morikazu Onji; Hisataka Moriwaki; Namiki Izum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Treatment of the hepatitis B virus and h

Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist

✍ Giovanni Raimondo; Carlo Saitta 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Advances in the treatment of chronic hep

Advances in the treatment of chronic hepatitis B virus infection

✍ Adriana R. Marques; Stephen E. Straus 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

Recent advances in our understanding of the replicative mechanism of HBV, and the development of potent nucleoside analogues as clinically effective inhibitors of the HIV reverse transcriptase or herpesvirus polymerases has opened a new era in the treatment of chronic HBV infection. Single agent the